Lonza Group reported CHF2.98B in Sales Revenues for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Akzo Nobel AKZA:NA EUR 2.86B 9M
Alcon AG ALC:SW USD 2.14B 77M
AstraZeneca AZN:LN USD 10.98B 211M
BASF BAS:GR EUR 21.95B 1.03B
Bayer BAYN:GR EUR 11.28B 1.54B
Beiersdorf BEI:GR EUR 2.25B 39M
Covestro 1COV:GR EUR 4.62B 85M
Fresenius FRE:GR EUR 10.46B 441M
Fresenius Medical Care FME:GR EUR 5.1B 339M
Genmab GEN:DC DKK 4.09B 925M
Givaudan GIVN:VX CHF 3.65B 341M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
GN Store Nord GN:DC DKK 4.7B 156M
Hikma Pharmaceutical HIK:LN USD 1.21B 124M
Johnson Matthey JMAT:LN GBP 7.33B 111M
Merck MRK:GR EUR 5.81B 238M
Novartis NOVN:VX USD 12.84B 243M
Philips PHIA:NA EUR 4.31B 133M
Roche Holding ROG:VX CHF 32.3B 207M
Sika AG SIKA:VX CHF 2.75B 350M
Smith & Nephew PLC SN/:LN 2.6B 13M
Solvay SOLB:BB EUR 4.41B 348M
William Demant Holding WDH:DC DKK 9.5B 121M